Literature DB >> 8162182

Transformation of mycobacterial species using hygromycin resistance as selectable marker.

T R Garbe1, J Barathi, S Barnini, Y Zhang, C Abou-Zeid, D Tang, R Mukherjee, D B Young.   

Abstract

Electroporation with shuttle plasmids carrying a kanamycin resistance gene as a selectable marker failed to generate transformants in two mycobacterial species currently being used in human vaccine trials (Mycobacterium w and Mycobacterium vaccae). In contrast, efficient transformation [10(3)-10(5) transformants (micrograms DNA)-1] was obtained using novel vectors with selection based on expression of resistance to hygromycin. The hygromycin resistance vector was also found to be more efficient than kanamycin resistance vectors for transformation of Mycobacterium smegmatis and Mycobacterium bovis BCG. The hygromycin resistance vector was used to overexpress superoxide dismutase of Mycobacterium tuberculosis in M. vaccae in a form suitable for detailed structural analysis. The potential use of this approach for generation of novel recombinant mycobacterial vaccines is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8162182     DOI: 10.1099/13500872-140-1-133

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  58 in total

Review 1.  Mycobacteria: bugs and bugbears (two steps forward and one step back).

Authors:  T Parish; N G Stoker
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

2.  The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages.

Authors:  J J De Voss; K Rutter; B G Schroeder; H Su; Y Zhu; C E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Both Corynebacterium diphtheriae DtxR(E175K) and Mycobacterium tuberculosis IdeR(D177K) are dominant positive repressors of IdeR-regulated genes in M. tuberculosis.

Authors:  Yukari C Manabe; Christine L Hatem; Anup K Kesavan; Justin Durack; John R Murphy
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Proteasomal control of cytokinin synthesis protects Mycobacterium tuberculosis against nitric oxide.

Authors:  Marie I Samanovic; Shengjiang Tu; Ondřej Novák; Lakshminarayan M Iyer; Fiona E McAllister; L Aravind; Steven P Gygi; Stevan R Hubbard; Miroslav Strnad; K Heran Darwin
Journal:  Mol Cell       Date:  2015-02-26       Impact factor: 17.970

5.  Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model.

Authors:  R Janssen; A Kruisselbrink; L Hoogteijling; J R Lamb; D B Young; J E Thole
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

6.  Construction and characterization of a Mycobacterium tuberculosis mutant lacking the alternate sigma factor gene, sigF.

Authors:  P Chen; R E Ruiz; Q Li; R F Silver; W R Bishai
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 7.  Techniques for genetic engineering in mycobacteria. Alternative host strains, DNA-transfer systems and vectors.

Authors:  J Hermans; J A de Bont
Journal:  Antonie Van Leeuwenhoek       Date:  1996-04       Impact factor: 2.271

8.  Targeted replacement of the mycocerosic acid synthase gene in Mycobacterium bovis BCG produces a mutant that lacks mycosides.

Authors:  A K Azad; T D Sirakova; L M Rogers; P E Kolattukudy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  Optimisation of bioluminescent reporters for use with mycobacteria.

Authors:  Nuria Andreu; Andrea Zelmer; Taryn Fletcher; Paul T Elkington; Theresa H Ward; Jorge Ripoll; Tanya Parish; Gregory J Bancroft; Ulrich Schaible; Brian D Robertson; Siouxsie Wiles
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

10.  Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia.

Authors:  Michael Berney; Gregory M Cook
Journal:  PLoS One       Date:  2010-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.